Qiagen NV | QIA - Net Income

Stock Price
41.39
Daily Change
0.21 0.51%
Monthly
-9.00%
Yearly
11.07%
Q1 Forecast
40.37

Qiagen NV reported $107.83M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
argenx SE USD 532.95M 188.69M Dec/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025